Literature DB >> 26247080

Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.

Jeremy Sugarman, Randy Stalter, Kevin Bokoch, Ting-Yuan Liu, Deborah Donnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26247080      PMCID： PMC4591048     

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  9 in total

Review 1.  Defining and describing benefit appropriately in clinical trials.

Authors:  N M King
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

2.  The incommensurability of research risks and benefits: practical help for research ethics committees.

Authors:  Douglas K Martin; Eric M Meslin; Nitsa Kohut; Peter A Singer
Journal:  IRB       Date:  1995 Mar-Apr

3.  Participation in clinical trials and long-term outcomes in Alzheimer's disease.

Authors:  S M Albert; M Sano; K Marder; D M Jacobs; J Brandt; M Albert; Y Stern
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

4.  Ethical issues in HIV prevention research with people who inject drugs.

Authors:  Jeremy Sugarman; Scott M Rose; David Metzger
Journal:  Clin Trials       Date:  2013-10-14       Impact factor: 2.486

5.  The "inclusion benefit" in clinical trials.

Authors:  J D Lantos
Journal:  J Pediatr       Date:  1999-02       Impact factor: 4.406

6.  Do sick newborn infants benefit from participation in a randomized clinical trial?

Authors:  B Schmidt; P Gillie; C Caco; J Roberts; R Roberts
Journal:  J Pediatr       Date:  1999-02       Impact factor: 4.406

7.  Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines.

Authors:  J D Clemens; F F van Loon; M Rao; D A Sack; F Ahmed; J Chakraborty; M R Khan; M Yunus; J R Harris; A M Svennerholm
Journal:  Am J Epidemiol       Date:  1992-04-15       Impact factor: 4.897

Review 8.  People who use drugs, HIV, and human rights.

Authors:  Ralf Jürgens; Joanne Csete; Joseph J Amon; Stefan Baral; Chris Beyrer
Journal:  Lancet       Date:  2010-08-07       Impact factor: 79.321

Review 9.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

Authors:  Jeffrey M Peppercorn; Jane C Weeks; E Francis Cook; Steven Joffe
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321
  9 in total
  4 in total

1.  The Role of Inclusion Benefits in Ethics Committee Assessment of Research Studies.

Authors:  Stuart Rennie; Suzanne Day; Allison Mathews; Adam Gilbertson; Winfred K Luseno; Joseph D Tucker; Gail E Henderson
Journal:  Ethics Hum Res       Date:  2019-05

2.  Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials.

Authors:  Michele P Andrasik; Fredericka Albertina Sesay; Abby Isaacs; Linda Oseso; Mary Allen
Journal:  J Acquir Immune Defic Syndr       Date:  2020-08-15       Impact factor: 3.731

3.  Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis.

Authors:  Adam Gilbertson; Elizabeth Poole Kelly; Stuart Rennie; Gail Henderson; JoAnn Kuruc; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-22       Impact factor: 2.205

4.  Reported Participation Benefits in International HIV Prevention Research with People Who Inject Drugs.

Authors:  Jeremy Sugarman; Ilana Trumble; Erica Hamilton; Riza Sarasvita; Kostyantyn Dumchev; Ha Viet; Irving Hoffman; William Miller; Brett Hanscom
Journal:  Ethics Hum Res       Date:  2019-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.